Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Antiinflammatory action of glucocorticoids--new mechanisms for old drugs.

Rhen T, Cidlowski JA.

N Engl J Med. 2005 Oct 20;353(16):1711-23. Review. No abstract available.

PMID:
16236742
2.

[New developments in glucocorticoid therapy: selective glucocorticoid receptor agonists, nitrosteroids and liposomal glucocorticoids].

Huisman AM, Jacobs JW, Buttgereit F, Bijlsma JW.

Ned Tijdschr Geneeskd. 2006 Mar 4;150(9):476-80. Review. Dutch.

PMID:
16553045
3.

The molecular complexity of glucocorticoid actions in inflammation - a four-ring circus.

Goulding NJ.

Curr Opin Pharmacol. 2004 Dec;4(6):629-36. Review.

PMID:
15525555
4.

Mechanisms of glucocorticoid receptor signaling during inflammation.

Smoak KA, Cidlowski JA.

Mech Ageing Dev. 2004 Oct-Nov;125(10-11):697-706. Review.

PMID:
15541765
5.

Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis.

Tuckermann JP, Kleiman A, McPherson KG, Reichardt HM.

Crit Rev Clin Lab Sci. 2005;42(1):71-104. Review.

PMID:
15697171
6.

[New developments in glucocorticoid therapy: selective glucocorticoid receptor agonists, nitrosteroids and liposomal glucocorticoids].

Spijker AJ.

Ned Tijdschr Geneeskd. 2006 May 27;150(21):1205; author reply 1205. Dutch. No abstract available.

PMID:
16768287
7.

[The mechanisms and significance of the endogenous antiinflammatory response].

Xu RB.

Sheng Li Ke Xue Jin Zhan. 1994 Oct;25(4):305-8. Review. Chinese. No abstract available.

PMID:
7709196
8.

Minimizing the side effects of glucocorticoid therapy.

Baxter JD.

Adv Intern Med. 1990;35:173-93. Review. No abstract available.

PMID:
2405592
9.

Targeting inflammation using selective glucocorticoid receptor modulators.

De Bosscher K, Haegeman G, Elewaut D.

Curr Opin Pharmacol. 2010 Aug;10(4):497-504. doi: 10.1016/j.coph.2010.04.007. Epub 2010 May 20. Review.

PMID:
20493772
10.

The search for safer glucocorticoid receptor ligands.

Rosen J, Miner JN.

Endocr Rev. 2005 May;26(3):452-64. Epub 2005 Apr 6. Review.

PMID:
15814846
11.

Genomic and nongenomic effects of glucocorticoids.

Stahn C, Buttgereit F.

Nat Clin Pract Rheumatol. 2008 Oct;4(10):525-33. doi: 10.1038/ncprheum0898. Epub 2008 Sep 2. Review.

PMID:
18762788
12.

[Mechanisms of the anti-inflammatory action of glucocorticoids].

Belovezhdov N.

Vutr Boles. 1985;24(6):1-5. Review. Bulgarian. No abstract available.

PMID:
3913140
13.

Anti-inflammatory actions of glucocorticoids: molecular mechanisms.

Barnes PJ.

Clin Sci (Lond). 1998 Jun;94(6):557-72. Review.

PMID:
9854452
14.

Molecular mechanisms of anti-inflammatory action of glucocorticoids.

Cato AC, Wade E.

Bioessays. 1996 May;18(5):371-8. Review.

PMID:
8639160
15.

Optimized glucocorticoid therapy: teaching old drugs new tricks.

Strehl C, Buttgereit F.

Mol Cell Endocrinol. 2013 Nov 5;380(1-2):32-40. doi: 10.1016/j.mce.2013.01.026. Epub 2013 Feb 8. Review.

PMID:
23403055
16.

Deflazacort: towards selective glucocorticoid receptor modulation?

Walker BR.

Clin Endocrinol (Oxf). 2000 Jan;52(1):13-5. No abstract available.

PMID:
10651748
17.

Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung diseases.

Newton R, Leigh R, Giembycz MA.

Pharmacol Ther. 2010 Feb;125(2):286-327. doi: 10.1016/j.pharmthera.2009.11.003. Epub 2009 Nov 22. Review.

PMID:
19932713
18.

Glucocorticoids and sepsis.

Allary J, Annane D.

Minerva Anestesiol. 2005 Dec;71(12):759-68. Review.

19.

Glucocorticoids.

Spies CM, Strehl C, van der Goes MC, Bijlsma JW, Buttgereit F.

Best Pract Res Clin Rheumatol. 2011 Dec;25(6):891-900. doi: 10.1016/j.berh.2011.11.002. Review.

PMID:
22265268
20.

Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice.

Kleiman A, Tuckermann JP.

Mol Cell Endocrinol. 2007 Sep 15;275(1-2):98-108. Epub 2007 May 18. Review.

PMID:
17587493

Supplemental Content

Support Center